Bexarotene: A Case Study of Medicare Part D's Specialty Drug Shortcomings

被引：1
|
作者：
Puri, Pranav [1 ]
Rajkumar, S. Vincent [2 ]
Shah, Nilay D. [3 ]
Pittelkow, Mark R. [4 ]
Mangold, Aaron R. [4 ]
机构：
[1] Mayo Clin, Alix Sch Med, Scottsdale, AZ USA
[2] Mayo Clin, Dept Hematol, Rochester, MN USA
[3] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA
[4] Mayo Clin, Dept Dermatol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA
来源：
MAYO CLINIC PROCEEDINGS | 2021年 / 96卷 / 10期
关键词：
PRICES;
D O I：
10.1016/j.mayocp.2021.06.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2519 / 2522
页数：4
相关论文
共 50 条
  • [21] Specialty biologic drug coverage under Medicare Part D: The experience of beneficiaries with rheumatoid arthritis (RA) and multiple sclerosis (MS)
    Polinski, Jennifer M.
    Mohr, Penny E.
    Johnson, Lorraine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S30 - S30
  • [22] Coverage for High-Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D
    Yazdany, Jinoos
    Dudley, R. Adams
    Chen, Randi
    Lin, Grace A.
    Tseng, Chien-Wen
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (06) : 1474 - 1480
  • [23] Nonlinear Pricing in Drug Benefits and Medication Use: The Case of Statin Compliance in Medicare Part D
    Jung, Kyoungrae
    Feldman, Roger
    McBean, A. Marshall
    HEALTH SERVICES RESEARCH, 2014, 49 (03) : 910 - 928
  • [24] Drug rebates in Medicare Part D: Excess patient costs in the case of hepatitis C treatments
    Arambadjis, Yorgos
    Butler, Mary
    Huckfeldt, Peter
    Schondelmeyer, Stephen
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (09): : 1290 - 1293
  • [25] Choice Set Size and Decision Making: The Case of Medicare Part D Prescription Drug Plans
    Bundorf, M. Kate
    Szrek, Helena
    MEDICAL DECISION MAKING, 2010, 30 (05) : 582 - 593
  • [26] Impactful improvements to Medicare Part D immunosuppressive drug coverage
    Potter, Lisa
    Crowther, Barrett
    Mcdermott, Jennifer K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (09) : 1468 - 1470
  • [27] The medicare part D drug program: Making the most of the benefit
    Utz, Sharon W.
    FAMILY & COMMUNITY HEALTH, 2008, 31 (04) : 350 - 351
  • [28] Assessment of Drug Consumption Patterns for Medicare Part D Patients
    Pedan, Alex
    Lu, Jingsong
    Varasteh, Laleh T.
    AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (05): : 323 - 327
  • [29] Part "D" for "defective" - The Medicare drug benefit chaos.
    Avorn, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13): : 1339 - 1341
  • [30] Drug proxies for identifying specific diagnoses in medicare Part D
    Livengood, K. B.
    Harada, A.
    Gong, S.
    Stockl, K.
    Le, L.
    Zhang, S.
    VALUE IN HEALTH, 2008, 11 (03) : A38 - A38
12345